These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 615505

  • 1. [Comparative study of uric acid concentration in serum and saliva of healthy or hyperuricemic subjects].
    Schermann JM, Meunier J, Ricordel I, Masbernard A, Giudicelli C.
    Ann Biol Clin (Paris); 1977; 35(6):467-72. PubMed ID: 615505
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
    Matzkies F, Neuwirth R, Berg G.
    Fortschr Med; 1976 Sep 16; 94(26):1427-9. PubMed ID: 976920
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
    Mertz DP.
    MMW Munch Med Wochenschr; 1978 Oct 20; 120(42):1387-90. PubMed ID: 101792
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Normurat (benzbromaron) in the treatment of gout].
    Bosmanský K, Trnavský K.
    Z Rheumatol; 1979 Oct 20; 38(9-10):342-8. PubMed ID: 525067
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of benzbromarone: a new uricosuric drug.
    Sorensen LB, Levinson DJ.
    Arthritis Rheum; 1976 Oct 20; 19(2):183-90. PubMed ID: 1259799
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P, Akkasilpa S, Deesomchok U.
    J Med Assoc Thai; 2002 Jun 20; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of hyperuricemia using daily doses of 50 and 25mg of benzbromarone].
    Matzkies F, Berg G, Minzlaff R.
    Fortschr Med; 1977 Jul 21; 95(27):1748-50. PubMed ID: 332605
    [Abstract] [Full Text] [Related]

  • 13. [Effect of benziodarone and benzbromarone on the uric acid level in the blood and urine and on the incidence of gout attacks].
    Brzozowska-Jurkowska AM.
    Reumatologia; 1980 Jul 21; 18(3):287-92. PubMed ID: 6999575
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical followup of the uricosuric drug--benzbromaron (author's transl)].
    Dzúrik R, Fedelesová V, Danĕková H, Hlavatá E.
    Bratisl Lek Listy; 1980 Nov 21; 74(5):547-54. PubMed ID: 7448590
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.